Anixa Biosciences Inc (ANIX): Revenue

Annual figures by period end, from SEC filings.

$210.0K
Year ended 2024-10-31
-25.7%
3-year compound annual growth
-3.4%
5-year compound annual growth
-24.9%
10-year compound annual growth
$9.26M2010-10-31: $730.7K2011-10-31: $1.00M2012-10-31: $940.0K2013-10-31: $388.9K2014-10-31: $3.67M2015-10-31: $9.26M2016-10-31: $300.0K2017-10-31: $362.5K2018-10-31: $1.11M2019-10-31: $250.0K2021-10-31: $512.0K2023-10-31: $210.0K2024-10-31: $210.0K$210.0K
2010-10-31 Revenue (USD) 2024-10-31
Period endedRevenueChange YoYSource filing
2024-10-31$210.0K0.0%2025-01-10, From 2023-11-01
2023-10-31$210.0Kn/a2024-01-16, From 2022-11-01
No annual figure between 2021-10-31 and 2023-10-31.
2021-10-31$512.0Kn/a2023-01-04, From 2020-11-01
No annual figure between 2019-10-31 and 2021-10-31.
2019-10-31$250.0K-77.5%2021-01-07, From 2018-11-01
2018-10-31$1.11M+206.9%2020-01-09, From 2017-11-01
2017-10-31$362.5K+20.8%2019-01-11, From 2016-11-01
2016-10-31$300.0K-96.8%2018-01-09, From 2015-11-01
2015-10-31$9.26M+152.4%2016-12-08, From 2014-11-01
2014-10-31$3.67M+843.1%2015-12-23, From 2013-11-01
2013-10-31$388.9K-58.6%2015-01-29, From 2012-11-01
2012-10-31$940.0K-6.3%2014-01-17, From 2011-11-01
2011-10-31$1.00M+37.3%2013-01-29, From 2010-11-01
2010-10-31$730.7Kn/a2012-01-30, From 2009-11-01